• Live
    • Audio Only
  • google plus
  • facebook
  • twitter
News > Cuba

Cuba Produces Its Own Sars-Cov-2 Antigen Diagnostic System

  • The authorities expect to deliver more than 1,600 UMELISA diagnostic systems by July 15.

    The authorities expect to deliver more than 1,600 UMELISA diagnostic systems by July 15. | Photo: Granma

Published 5 July 2021
Opinion

The antigen test can identify the virus in four hours. The firsts 644 kits were sent to the Medicines Marketing and Distribution Company (EMCOMED) for mass-scale production and distribution.

Cuban President Miguel Díaz-Canel announced that the UMELISA SARS-CoV-2 antigen diagnostic system aims to reinforce the country's response to the COVID-19 pandemic amid a surge in cases.

RELATED:

Venezuela Successfully Applies Cuba's Abdala COVID-19

"Another achievement of Cuban science. Umelisa SARS-COV-2 antigen, a 100% Cuban diagnostic system," the president said via Twitter.

"Another achievement of Cuban science. Umelisa SARS-COV-2 antigen, a 100% Cuban diagnostic system."

The antigen test can identify the virus in four hours. The firsts 644 kits were sent to the Medicines Marketing and Distribution Company (EMCOMED) for mass-scale production and distribution.

The authorities expect to deliver more than 1,600 UMELISA diagnostic systems by July 15 and provide the health system with 705,000 kits.

Comment
0
Comments
Post with no comments.